Alnylam Pharmaceuticals | ALNY

Aktienkurs
295.89
Täglich Wechseln
-7.11 -2.35%
Monatlich
-9.58%
Jährlich
14.53%
Q2 Prognose
289.95

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-04-30 FY2026Q1 AM 1.99 0.99 -0.01
2026-02-12 FY2025Q4 AM 1.25 1.27 0.06
2025-10-30 FY2025Q3 AM 2.90 0.27 -0.50
2025-07-31 FY2025Q2 AM 0.32 -0.73 0.56
2025-05-01 FY2025Q1 AM -0.01 -0.94 -0.16



Preis Chg Tag Jahr Datum
Takeda 5,310.00 71.00 1.36% 24.07% 2026-05-07
Acadia Pharmaceuticals 22.56 1.08 5.03% 33.25% 2026-05-07
Agios Pharmaceuticals 27.53 0.55 2.04% -1.82% 2026-05-07
Alnylam Pharmaceuticals 295.89 -7.11 -2.35% 14.53% 2026-05-07
Amgen 329.09 -2.02 -0.61% 20.97% 2026-05-07
Arrowhead Research 77.95 -1.19 -1.50% 488.30% 2026-05-07
Tectonic Therapeutic 26.87 -2.15 -7.41% 27.83% 2026-05-07
BioCryst Pharmaceuticals 8.90 0.07 0.79% -10.28% 2026-05-07
BioMarin Pharmaceutical 54.12 -0.48 -0.88% -9.53% 2026-05-07
Incyte 97.79 -2.06 -2.06% 63.72% 2026-05-07

Preis Tag Jahr Datum
USND 25806 -32.75 -0.13% 43.94% 2026-05-07